{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T05:47:46Z","timestamp":1775022466343,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T00:00:00Z","timestamp":1680566400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA048022"],"award-info":[{"award-number":["R01DA048022"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01DA048022"],"award-info":[{"award-number":["R01DA048022"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Opioids accounted for 75% of drug overdoses in the USA in 2020, with rural states particularly impacted by the opioid crisis. While medication-assisted treatment (MAT) with Suboxone remains one of the more efficacious treatments for opioid use disorder (OUD), approximately 40% of people receiving Suboxone for outpatient MAT for OUD (MOUD) relapse within the first 6 months of treatment. We developed the smartphone app-based intervention OptiMAT as an adjunctive intervention to improve MOUD outcomes. The aims of this study are to (1) evaluate the efficacy of adjunctive OptiMAT use in reducing opioid misuse among people receiving MOUD and (2) evaluate the role of specific OptiMAT features in reducing opioid misuse, including the use of GPS-driven just-in-time intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will conduct a two-arm, single-blind, randomized controlled trial of adults receiving outpatient MOUD in the greater Little Rock AR area. Participants are English-speaking adults ages 18 or older recently enrolled in outpatient MOUD at one of our participating study clinics. Participants will be allocated via 1:1 randomized block design to (1) MOUD with adjunctive use of OptiMAT (MOUD+OptiMAT) or (2) MOUD without OptiMAT (MOUD-only). Our blinded research statistician will evaluate differences between the two groups in opioid misuse (as determined by quantitative urinalysis conducted by clinical lab staff blinded to group membership) during the 6-months following study enrolment. Secondary analyses will evaluate if OptiMAT-usage patterns within the MOUD+OptiMAT group predict opioid misuse or continued abstinence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This study will test if adjunctive use of OptiMAT improve MOUD outcomes. Study findings could lead to expansion of OptiMAT into rural clinical settings, and the identification of OptiMAT features which best predict positive clinical outcome could lead to refinement of this and similar smartphone app-based interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      ClinicalTrials.gov\nidentifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05336188\">NCT05336188<\/jats:ext-link>\n                      , registered March 21, 2022.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13063-023-07213-3","type":"journal-article","created":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T07:09:37Z","timestamp":1680592177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Smartphone intervention to optimize medication-assisted treatment outcomes for opioid use disorder: study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"24","author":[{"suffix":"Jr.","given":"Ronald G.","family":"Thompson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Bollinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Mancino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Hasin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaotong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith A.","family":"Bush","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clint D.","family":"Kilts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2940-2746","authenticated-orcid":false,"given":"G. Andrew","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,4]]},"reference":[{"key":"7213_CR1","unstructured":"Centers for Disease Control and Prevention. U.S. drug overdose death rates. Available from: https:\/\/www.cdc.gov\/drugoverdose\/deaths\/index.html"},{"key":"7213_CR2","unstructured":"Centers for Disease Control and Prevention. U.S. opioid dispensing rate maps. Available from: https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html"},{"issue":"9358","key":"7213_CR3","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","volume":"361","author":"J Kakko","year":"2003","unstructured":"Kakko J, Svanborg KD, Kreek MJ, Heilig M. 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial. Lancet. 2003;361(9358):662\u20138.","journal-title":"Lancet."},{"key":"7213_CR4","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jsat.2017.04.016","volume":"85","author":"EV Nunes","year":"2018","unstructured":"Nunes EV, Gordon M, Friedmann PD, Fishman MJ, Lee JD, Chen DT, et al. Relapse to opioid use disorder after inpatient treatment: protective effect of injection naltrexone. J Substance Abuse Treat. 2018;85:49\u201355.","journal-title":"J Substance Abuse Treat."},{"issue":"13","key":"7213_CR5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1056\/NEJMoa1505409","volume":"374","author":"JD Lee","year":"2016","unstructured":"Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA, et al. Extended-release naltrexone to prevent opioid relapse in criminal justice offenders. N Engl J Med. 2016;374(13):1232\u201342.","journal-title":"N Engl J Med."},{"key":"7213_CR6","doi-asserted-by":"crossref","unstructured":"Gomez-Marcos MA, Patino-Alonso MC, Recio-Rodriguez JI, Agudo-Conde C, Romaguera-Bosch M, Magdalena-Gonzalez O, et al. Short- and long-term effectiveness of a smartphone application for improving measures of adiposity: a randomised clinical trial - EVIDENT II study. Eur J Cardiovasc Nurs. 2018:1474515118761870.","DOI":"10.1177\/1474515118761870"},{"issue":"5","key":"7213_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1002\/oby.21063","volume":"23","author":"CK Martin","year":"2015","unstructured":"Martin CK, Miller AC, Thomas DM, Champagne CM, Han H, Church T. Efficacy of SmartLoss, a smartphone-based weight loss intervention: results from a randomized controlled trial. Obesity (Silver Spring). 2015;23(5):935\u201342.","journal-title":"Obesity (Silver Spring)."},{"key":"7213_CR8","doi-asserted-by":"crossref","unstructured":"Bond DS, Thomas JG, Raynor HA, Moon J, Sieling J, Trautvetter J, et al. B-MOBILE--a smartphone-based intervention to reduce sedentary time in overweight\/obese individuals: a within-subjects experimental trial. PLoS ONE. 2014;9(6):e100821.","DOI":"10.1371\/journal.pone.0100821"},{"issue":"4","key":"7213_CR9","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1097\/JCN.0b013e318250a3e7","volume":"28","author":"J Stephens","year":"2013","unstructured":"Stephens J, Allen J. Mobile phone interventions to increase physical activity and reduce weight: a systematic review. J Cardiovasc Nurs. 2013;28(4):320\u20139.","journal-title":"J Cardiovasc Nurs."},{"key":"7213_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.drugalcdep.2014.07.006","volume":"143","author":"JB Bricker","year":"2014","unstructured":"Bricker JB, Mull KE, Kientz JA, Vilardaga R, Mercer LD, Akioka KJ, et al. Randomized, controlled pilot trial of a smartphone app for smoking cessation using acceptance and commitment therapy. Drug Alcohol Depend. 2014;143:87\u201394.","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"7213_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1089\/tmj.2013.0169","volume":"20","author":"DB Buller","year":"2014","unstructured":"Buller DB, Borland R, Bettinghaus EP, Shane JH, Zimmerman DE. Randomized trial of a smartphone mobile application compared to text messaging to support smoking cessation. Telemed J E Health. 2014;20(3):206\u201314.","journal-title":"Telemed J E Health."},{"issue":"7","key":"7213_CR12","doi-asserted-by":"publisher","first-page":"959","DOI":"10.4088\/JCP.14m09053","volume":"76","author":"VL Carpenter","year":"2015","unstructured":"Carpenter VL, Hertzberg JS, Kirby AC, Calhoun PS, Moore SD, Dennis MF, et al. Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans. J Clin Psychiatry. 2015;76(7):959\u201364.","journal-title":"J Clin Psychiatry."},{"issue":"5","key":"7213_CR13","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jamapsychiatry.2013.4642","volume":"71","author":"DH Gustafson","year":"2014","unstructured":"Gustafson DH, McTavish FM, Chih MY, Atwood AK, Johnson RA, Boyle MG, et al. A smartphone application to support recovery from alcoholism: a randomized clinical trial. JAMA Psychiatry. 2014;71(5):566\u201372.","journal-title":"JAMA Psychiatry."},{"issue":"2","key":"7213_CR14","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1037\/a0038620","volume":"83","author":"VM Gonzalez","year":"2015","unstructured":"Gonzalez VM, Dulin PL. Comparison of a smartphone app for alcohol use disorders with an Internet-based intervention plus bibliotherapy: a pilot study. J Consult Clin Psychol. 2015;83(2):335\u201345.","journal-title":"J Consult Clin Psychol."},{"issue":"4","key":"7213_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1080\/08897077.2014.970323","volume":"36","author":"ML Dennis","year":"2015","unstructured":"Dennis ML, Scott CK, Funk RR, Nicholson L. A pilot study to examine the feasibility and potential effectiveness of using smartphones to provide recovery support for adolescents. Subst Abus. 2015;36(4):486\u201392.","journal-title":"Subst Abus."},{"issue":"1","key":"7213_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1940-0640-9-5","volume":"9","author":"DS Hasin","year":"2014","unstructured":"Hasin DS, Aharonovich E, Greenstein E. HealthCall for the smartphone: technology enhancement of brief intervention in HIV alcohol dependent patients. Addict Sci Clin Pract. 2014;9(1):5.","journal-title":"Addict Sci Clin Pract."},{"key":"7213_CR17","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jsat.2017.09.013","volume":"83","author":"E Aharonovich","year":"2017","unstructured":"Aharonovich E, Stohl M, Cannizzaro D, Hasin D. HealthCall delivered via smartphone to reduce co-occurring drug and alcohol use in HIV-infected adults: a randomized pilot trial. J Subst Abuse Treat. 2017;83:15\u201326.","journal-title":"J Subst Abuse Treat."},{"key":"7213_CR18","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jsat.2016.12.009","volume":"74","author":"E Aharonovich","year":"2017","unstructured":"Aharonovich E, Sarvet A, Stohl M, DesJarlais D, Tross S, Hurst T, et al. Reducing non-injection drug use in HIV primary care: A randomized trial of brief motivational interviewing, with and without HealthCall, a technology-based enhancement. J Subst Abuse Treat. 2017;74:71\u20139.","journal-title":"J Subst Abuse Treat."},{"issue":"7","key":"7213_CR19","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/add.12127","volume":"108","author":"DS Hasin","year":"2013","unstructured":"Hasin DS, Aharonovich E, O\u2019Leary A, Greenstein E, Pavlicova M, Arunajadai S, et al. Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancement. Addiction. 2013;108(7):1230\u201340.","journal-title":"Addiction."},{"key":"7213_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2022.108733","volume":"138","author":"DS Hasin","year":"2022","unstructured":"Hasin DS, Aharonovich E, Zingman BS, Stohl M, Walsh C, Elliott JC, et al. HealthCall: a randomized trial assessing a smartphone enhancement of brief interventions to reduce heavy drinking in HIV care. J Substance Abuse Treat. 2022;138:108733.","journal-title":"J Substance Abuse Treat."},{"issue":"6","key":"7213_CR21","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1037\/adb0000570","volume":"34","author":"RG Thompson","year":"2020","unstructured":"Thompson RG, Aivadyan C, Stohl M, Aharonovich E, Hasin DS. Smartphone application plus brief motivational intervention reduces substance use and sexual risk behaviors among homeless young adults: results from a randomized controlled trial. Psychol Addict Behav. 2020;34(6):641\u20139.","journal-title":"Psychol Addict Behav."},{"key":"7213_CR22","first-page":"208","volume":"175","author":"W Ling","year":"1997","unstructured":"Ling W, Shoptaw S, Wesson D, Rawson RA, Compton M, Klett CJ. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res Monogr. 1997;175:208\u201320.","journal-title":"NIDA Res Monogr."},{"issue":"2","key":"7213_CR23","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0005-7967(79)90025-1","volume":"17","author":"LC Sobell","year":"1979","unstructured":"Sobell LC, Maisto SA, Sobell MB, Cooper AM. Reliability of alcohol abusers\u2019 self-reports of drinking behavior. Behav Res Therapy. 1979;17(2):157\u201360.","journal-title":"Behav Res Therapy."},{"issue":"3","key":"7213_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/wps.20472","volume":"16","author":"J Firth","year":"2017","unstructured":"Firth J, Torous J, Nicholas J, Carney R, Pratap A, Rosenbaum S, et al. The efficacy of smartphone-based mental health interventions for depressive symptoms: a meta-analysis of randomized controlled trials. World Psychiatry. 2017;16(3):287\u201398.","journal-title":"World Psychiatry."},{"key":"7213_CR25","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jad.2017.04.046","volume":"218","author":"J Firth","year":"2017","unstructured":"Firth J, Torous J, Nicholas J, Carney R, Rosenbaum S, Sarris J. Can smartphone mental health interventions reduce symptoms of anxiety? A meta-analysis of randomized controlled trials. J Affect Disord. 2017;218:15\u201322.","journal-title":"J Affect Disord."},{"issue":"8","key":"7213_CR26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/1357633X16664205","volume":"23","author":"AK Gilmore","year":"2017","unstructured":"Gilmore AK, Wilson SM, Skopp NA, Osenbach JE, Reger G. A systematic review of technology-based interventions for co-occurring substance use and trauma symptoms. J Telemed Telecare. 2017;23(8):701\u20139.","journal-title":"J Telemed Telecare."},{"key":"7213_CR27","doi-asserted-by":"crossref","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u2013381.","DOI":"10.1016\/j.jbi.2008.08.010"},{"issue":"9","key":"7213_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","volume":"15","author":"HF Hsieh","year":"2005","unstructured":"Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15(9):1277\u201388.","journal-title":"Qual Health Res."},{"key":"7213_CR29","unstructured":"Crabtree BF, Miller WF. A template approach to text analysis: developing and using codebooks. In: Doing qualitative research. Thousand Oaks: Sage Publications, Inc; 1992. p. 93\u2013109. (Research methods for primary care, Vol. 3)."},{"issue":"1","key":"7213_CR30","doi-asserted-by":"publisher","first-page":"160940691771213","DOI":"10.1177\/1609406917712131","volume":"16","author":"DC Watkins","year":"2017","unstructured":"Watkins DC. Rapid and rigorous qualitative data analysis: the \u201cRADaR\u201d technique for applied research. Int J Qualitative Methods. 2017;16(1):1609406917712131.","journal-title":"Int J Qualitative Methods."},{"key":"7213_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-15671-8","volume-title":"Analyzing qualitative data with MAXQDA: text, audio, and video","author":"U Kuckartz","year":"2019","unstructured":"Kuckartz U, R\u00e4diker S. Analyzing qualitative data with MAXQDA: text, audio, and video. Cham: Springer International Publishing; 2019. [cited 2022 Nov 8]. Available from: http:\/\/link.springer.com\/10.1007\/978-3-030-15671-8"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07213-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07213-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07213-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,4]],"date-time":"2023-04-04T07:25:46Z","timestamp":1680593146000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07213-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7213"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07213-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2511936\/v1","asserted-by":"object"}]},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,4]]},"assertion":[{"value":"24 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study protocol has been approved by the UAMS Institutional Review Board (protocol #274084). Per the protocol, the study investigators and staff will obtain written informed consent from all study participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable: no identifying images or other personal or clinical details of participants are presented here nor will be presented in reports of the trial results. Informed consent materials are attached as supplementary materials. Relevant protections from supplementary materials against the loss of confidentiality are re-iterated in the \u201cProtection against loss of confidentiality\u201d section.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"Drs. James, Thompson, and Bollinger will apply for patent and\/or trademark protection for the OptiMAT smartphone app. The authors declare no other competing financial or non-financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"255"}}